626 related articles for article (PubMed ID: 28000005)
21. Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes.
Graff-Radford J; Lesnick TG; Mielke MM; Constantopoulos E; Rabinstein AA; Przybelski SA; Vemuri P; Botha H; Jones DT; Ramanan VK; Petersen RC; Knopman DS; Boeve BF; Murray ME; Dickson DW; Jack CR; Kantarci K; Reichard RR
J Alzheimers Dis; 2021; 81(1):113-122. PubMed ID: 33720897
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.
Carmona-Iragui M; Fernández-Arcos A; Alcolea D; Piazza F; Morenas-Rodriguez E; Antón-Aguirre S; Sala I; Clarimon J; Dols-Icardo O; Camacho V; Sampedro F; Munuera J; Nuñez-Marin F; Lleó A; Fortea J; Gómez-Ansón B; Blesa R
J Alzheimers Dis; 2016; 50(1):1-7. PubMed ID: 26639966
[TBL] [Abstract][Full Text] [Related]
23. Cerebellar Microbleed Distribution Patterns and Cerebral Amyloid Angiopathy.
Pasi M; Pongpitakmetha T; Charidimou A; Singh SD; Tsai HH; Xiong L; Boulouis G; Warren AD; Rosand J; Frosch MP; Viswanathan A; Gurol ME; Greenberg SM
Stroke; 2019 Jul; 50(7):1727-1733. PubMed ID: 31159702
[TBL] [Abstract][Full Text] [Related]
24. Microbleeds colocalize with enlarged juxtacortical perivascular spaces in amnestic mild cognitive impairment and early Alzheimer's disease: A 7 Tesla MRI study.
Bouvy WH; van Veluw SJ; Kuijf HJ; Zwanenburg JJ; Kappelle JL; Luijten PR; Koek HL; Geerlings MI; Biessels GJ;
J Cereb Blood Flow Metab; 2020 Apr; 40(4):739-746. PubMed ID: 30890076
[TBL] [Abstract][Full Text] [Related]
25. Association of Cerebral Microbleeds with Cognitive Decline: A Longitudinal Study.
Li L; Wu DH; Li HQ; Tan L; Xu W; Dong Q; Tan L; Yu JT;
J Alzheimers Dis; 2020; 75(2):571-579. PubMed ID: 32310166
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
[TBL] [Abstract][Full Text] [Related]
27. Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment.
Shams S; Granberg T; Martola J; Charidimou A; Li X; Shams M; Fereshtehnejad SM; Cavallin L; Aspelin P; Wiberg-Kristoffersen M; Wahlund LO
J Cereb Blood Flow Metab; 2017 Mar; 37(3):1006-1013. PubMed ID: 27178426
[TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease.
Shams M; Martola J; Charidimou A; Granberg T; Ferreira D; Westman E; Wintermark M; Iv M; Larvie M; Kristoffersen Wiberg M; Kaijser M; Forsgard N; Zetterberg H; Wahlund LO; Shams S
J Alzheimers Dis; 2020; 78(3):1229-1236. PubMed ID: 33104030
[TBL] [Abstract][Full Text] [Related]
29. Histopathological Correlates of Lobar Microbleeds in False-Positive Cerebral Amyloid Angiopathy Cases.
Perosa V; Auger CA; Zanon Zotin MC; Oltmer J; Frosch MP; Viswanathan A; Greenberg SM; van Veluw SJ
Ann Neurol; 2023 Nov; 94(5):856-870. PubMed ID: 37548609
[TBL] [Abstract][Full Text] [Related]
30. Cerebral Microbleeds and Cortical Superficial Siderosis in Patients Presenting With Minor Cerebrovascular Events.
Zerna C; Modi J; Bilston L; Shoamanesh A; Coutts SB; Smith EE
Stroke; 2016 Sep; 47(9):2236-41. PubMed ID: 27507863
[TBL] [Abstract][Full Text] [Related]
31. White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.
Freeze WM; Jacobs HI; Gronenschild EH; Jansen JF; Burgmans S; Aalten P; Clerx L; Vos SJ; van Buchem MA; Barkhof F; van der Flier WM; Verbeek MM; Rikkert MO; Backes WH; Verhey FR;
J Alzheimers Dis; 2017; 55(1):333-342. PubMed ID: 27662299
[TBL] [Abstract][Full Text] [Related]
32. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.
Boulouis G; Charidimou A; Jessel MJ; Xiong L; Roongpiboonsopit D; Fotiadis P; Pasi M; Ayres A; Merrill ME; Schwab KM; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
Neurology; 2017 Feb; 88(9):878-884. PubMed ID: 28130469
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of Diagnosis and Treatment of 6 Cases of Cerebral Amyloid Angiopathy-related Inflammation].
Zhong D; Yang TH; Zhang Q; Wu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 51(1):107-112. PubMed ID: 31950799
[TBL] [Abstract][Full Text] [Related]
34. Cerebral small vessel disease and the risk of Alzheimer's disease: A systematic review.
Liu Y; Braidy N; Poljak A; Chan DKY; Sachdev P
Ageing Res Rev; 2018 Nov; 47():41-48. PubMed ID: 29898422
[TBL] [Abstract][Full Text] [Related]
35. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease.
Lee S; Zimmerman ME; Narkhede A; Nasrabady SE; Tosto G; Meier IB; Benzinger TLS; Marcus DS; Fagan AM; Fox NC; Cairns NJ; Holtzman DM; Buckles V; Ghetti B; McDade E; Martins RN; Saykin AJ; Masters CL; Ringman JM; Fӧrster S; Schofield PR; Sperling RA; Johnson KA; Chhatwal JP; Salloway S; Correia S; Jack CR; Weiner M; Bateman RJ; Morris JC; Mayeux R; Brickman AM;
PLoS One; 2018; 13(5):e0195838. PubMed ID: 29742105
[TBL] [Abstract][Full Text] [Related]
36. Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
Planton M; Saint-Aubert L; Raposo N; Payoux P; Salabert AS; Albucher JF; Olivot JM; Péran P; Pariente J
J Alzheimers Dis; 2020; 73(4):1607-1614. PubMed ID: 31958082
[TBL] [Abstract][Full Text] [Related]
37. White matter hyperintensities: relationship to amyloid and tau burden.
Graff-Radford J; Arenaza-Urquijo EM; Knopman DS; Schwarz CG; Brown RD; Rabinstein AA; Gunter JL; Senjem ML; Przybelski SA; Lesnick T; Ward C; Mielke MM; Lowe VJ; Petersen RC; Kremers WK; Kantarci K; Jack CR; Vemuri P
Brain; 2019 Aug; 142(8):2483-2491. PubMed ID: 31199475
[TBL] [Abstract][Full Text] [Related]
38. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
40. Case of Cerebral Amyloid Angiopathy-Related Inflammation - Is the Absence of Cerebral Microbleeds A Good Prognostic Sign?
Liang JW; Zhang W; Sarlin J; Boniece I
J Stroke Cerebrovasc Dis; 2015 Nov; 24(11):e319-22. PubMed ID: 26341733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
